12-89421157-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_172240.3(POC1B):c.1433G>T(p.Ser478Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000554 in 1,582,182 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S478N) has been classified as Benign.
Frequency
Consequence
NM_172240.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POC1B | NM_172240.3 | c.1433G>T | p.Ser478Ile | missense_variant | 12/12 | ENST00000313546.8 | NP_758440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POC1B | ENST00000313546.8 | c.1433G>T | p.Ser478Ile | missense_variant | 12/12 | 1 | NM_172240.3 | ENSP00000323302.3 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 432AN: 152158Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000811 AC: 193AN: 238120Hom.: 2 AF XY: 0.000599 AC XY: 77AN XY: 128482
GnomAD4 exome AF: 0.000307 AC: 439AN: 1429906Hom.: 3 Cov.: 30 AF XY: 0.000254 AC XY: 179AN XY: 705774
GnomAD4 genome AF: 0.00287 AC: 437AN: 152276Hom.: 2 Cov.: 32 AF XY: 0.00274 AC XY: 204AN XY: 74456
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
POC1B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at